These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 31775840)

  • 1. Increased β-Lactams dosing regimens improve clinical outcome in critically ill patients with augmented renal clearance treated for a first episode of hospital or ventilator-acquired pneumonia: a before and after study.
    Carrié C; Chadefaux G; Sauvage N; de Courson H; Petit L; Nouette-Gaulain K; Pereira B; Biais M
    Crit Care; 2019 Nov; 23(1):379. PubMed ID: 31775840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between augmented renal clearance and clinical failure of antibiotic treatment in brain-injured patients with ventilator-acquired pneumonia: A preliminary study.
    Carrie C; Bentejac M; Cottenceau V; Masson F; Petit L; Cochard JF; Sztark F
    Anaesth Crit Care Pain Med; 2018 Feb; 37(1):35-41. PubMed ID: 28756331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of β-lactams administered by continuous infusion: a prospective observational study.
    Carrié C; Petit L; d'Houdain N; Sauvage N; Cottenceau V; Lafitte M; Foumenteze C; Hisz Q; Menu D; Legeron R; Breilh D; Sztark F
    Int J Antimicrob Agents; 2018 Mar; 51(3):443-449. PubMed ID: 29180280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-drug versus combination antimicrobial therapy in critically ill patients with hospital-acquired pneumonia and ventilator-associated pneumonia due to Gram-negative pathogens: a multicenter retrospective cohort study.
    Barbier F; Dupuis C; Buetti N; Schwebel C; Azoulay É; Argaud L; Cohen Y; Hong Tuan Ha V; Gainnier M; Siami S; Forel JM; Adrie C; de Montmollin É; Reignier J; Ruckly S; Zahar JR; Timsit JF;
    Crit Care; 2024 Jan; 28(1):10. PubMed ID: 38172969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.
    Pugh R; Grant C; Cooke RP; Dempsey G
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007577. PubMed ID: 26301604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Machine Learning To Define the Impact of Beta-Lactam Early and Cumulative Target Attainment on Outcomes in Intensive Care Unit Patients with Hospital-Acquired and Ventilator-Associated Pneumonia.
    Alshaer MH; Maranchick N; Bai C; Maguigan KL; Shoulders B; Felton TW; Mathew SK; Mardini MT; Peloquin CA
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0056322. PubMed ID: 35699444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: an observational prospective cohort study.
    Huttner A; Von Dach E; Renzoni A; Huttner BD; Affaticati M; Pagani L; Daali Y; Pugin J; Karmime A; Fathi M; Lew D; Harbarth S
    Int J Antimicrob Agents; 2015 Apr; 45(4):385-92. PubMed ID: 25656151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults.
    Pugh R; Grant C; Cooke RP; Dempsey G
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007577. PubMed ID: 21975771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between augmented renal clearance and clinical outcomes in patients receiving β-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial.
    Udy AA; Dulhunty JM; Roberts JA; Davis JS; Webb SAR; Bellomo R; Gomersall C; Shirwadkar C; Eastwood GM; Myburgh J; Paterson DL; Starr T; Paul SK; Lipman J; ;
    Int J Antimicrob Agents; 2017 May; 49(5):624-630. PubMed ID: 28286115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging trends of nosocomial pneumonia in intensive care unit of a tertiary care public teaching hospital in Western India.
    Bhadade R; Harde M; deSouza R; More A; Bharmal R
    Ann Afr Med; 2017; 16(3):107-113. PubMed ID: 28671150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effectiveness of cefoperazone-sulbactam vs. piperacillin-tazobactam for the treatment of pneumonia in elderly patients.
    Huang CT; Chen CH; Chen WC; Wang YT; Lai CC; Fu PK; Kuo LK; Chen CM; Fang WF; Tu CY; Ku SC
    Int J Antimicrob Agents; 2022 Jan; 59(1):106491. PubMed ID: 34871744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covariate determinants of effective dosing regimens for time-dependent beta-lactam antibiotics for critically ill patients.
    Kaska M; Havel E; Selke-Krulichova I; Safranek P; Bezouska J; Martinkova J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Sep; 162(3):219-226. PubMed ID: 29582860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic/Pharmacodynamic Optimization of Hospital-Acquired and Ventilator-Associated Pneumonia: Challenges and Strategies.
    Abouelhassan YP; Nicolau D
    Semin Respir Crit Care Med; 2022 Apr; 43(2):175-182. PubMed ID: 35088402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized ß-lactam dosing in patients with coronavirus disease 2019 (COVID-19) and pneumonia: A retrospective analysis on pharmacokinetics and pharmacokinetic target attainment.
    Chiriac U; Frey OR; Roehr AC; Koeberer A; Gronau P; Fuchs T; Roberts JA; Brinkmann A
    Medicine (Baltimore); 2021 Jun; 100(22):e26253. PubMed ID: 34087915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimization.
    Sime FB; Udy AA; Roberts JA
    Curr Opin Pharmacol; 2015 Oct; 24():1-6. PubMed ID: 26119486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbial cause of ICU-acquired pneumonia: hospital-acquired pneumonia versus ventilator-associated pneumonia.
    Luyt CE; Hékimian G; Koulenti D; Chastre J
    Curr Opin Crit Care; 2018 Oct; 24(5):332-338. PubMed ID: 30036192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a multiplex molecular pneumonia panel and real-world impact on antimicrobial stewardship among patients with hospital-acquired and ventilator-associated pneumonia in intensive care units.
    Chen CL; Tseng HY; Chen WC; Liang SJ; Tu CY; Lin YC; Hsueh PR
    J Microbiol Immunol Infect; 2024 Jun; 57(3):480-489. PubMed ID: 38471985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftaroline fosamil for the treatment of hospital-acquired pneumonia and ventilator-associated pneumonia.
    Kaye KS; Udeani G; Cole P; Friedland HD
    Hosp Pract (1995); 2015; 43(3):144-9. PubMed ID: 25956849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.